Javier Narváez, Judith Palacios-Olid, María Jesús García de Yebenes, Susana Holgado, Alejandro Olivé, Ivette Casafont-Solé, Santos Castañeda, Cristina Valero-Martínez, María Martín-López, Patricia E Carreira, Maribel Mora-Limiñana, Laura Nuño-Nuño, Angel Robles-Marhuenda, Pilar Bernabeu, José Campos, Jenaro Graña, Vera Ortiz-Santamaria, Marisol Camacho-Lovillo, Carmen Vargas, Judith Sanchez-Manubens, Jordi Anton
{"title":"Non-Classical Complications of Adult-Onset Still's Disease: A Multicenter Spanish Study.","authors":"Javier Narváez, Judith Palacios-Olid, María Jesús García de Yebenes, Susana Holgado, Alejandro Olivé, Ivette Casafont-Solé, Santos Castañeda, Cristina Valero-Martínez, María Martín-López, Patricia E Carreira, Maribel Mora-Limiñana, Laura Nuño-Nuño, Angel Robles-Marhuenda, Pilar Bernabeu, José Campos, Jenaro Graña, Vera Ortiz-Santamaria, Marisol Camacho-Lovillo, Carmen Vargas, Judith Sanchez-Manubens, Jordi Anton","doi":"10.3390/jcm14010285","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> To investigate the prevalence and clinical spectrum of atypical or non-classical complications in adult-onset Still's disease (AOSD) beyond macrophage activation syndrome (MAS) and to identify factors linked to their occurrence. <b>Methods:</b> Multicenter cross-sectional study of AODS cases included in the Spanish registry on Still's disease. <b>Results:</b> This study included 107 patients (67% women), of whom 64 (59.8%) developed non-classical complications. These include macrophage activation syndrome in 9.5%, atypical skin manifestations in 38.8%, cardiac involvement in 22.7% (comprising pericarditis, myocarditis, pulmonary arterial hypertension, and noninfectious endocarditis), pleuritis in 28.9%, transient pulmonary infiltrates in 4%, significant headache in 14.1%, lower abdominal pain with evidence of peritonitis in 8.4%, and secondary amyloidosis in 0.9%. In the multivariate logistic regression analysis, lymphadenopathy (OR 2.85, 95% CI 1.03-7.91, <i>p</i> = 0.044) and the systemic score system (SSC) index (OR 1.86, 95% CI 1.29-2.69, <i>p</i> = 0.001) were independently associated with the development of non-classical clinical manifestations. In contrast, typical exanthema was associated with a reduced risk of these complications (OR 0.32, 95% CI 0.11-0.95, <i>p</i> = 0.041). <b>Conclusions:</b> In addition to the typical clinical manifestations and MAS, a significant proportion of patients with AOSD develop uncommon complications, some of which can be potentially life-threatening. These should be considered in the evaluation and follow-up of patients. Early recognition and prompt management are crucial to significantly reduce morbidity and mortality.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 1","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11721743/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jcm14010285","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To investigate the prevalence and clinical spectrum of atypical or non-classical complications in adult-onset Still's disease (AOSD) beyond macrophage activation syndrome (MAS) and to identify factors linked to their occurrence. Methods: Multicenter cross-sectional study of AODS cases included in the Spanish registry on Still's disease. Results: This study included 107 patients (67% women), of whom 64 (59.8%) developed non-classical complications. These include macrophage activation syndrome in 9.5%, atypical skin manifestations in 38.8%, cardiac involvement in 22.7% (comprising pericarditis, myocarditis, pulmonary arterial hypertension, and noninfectious endocarditis), pleuritis in 28.9%, transient pulmonary infiltrates in 4%, significant headache in 14.1%, lower abdominal pain with evidence of peritonitis in 8.4%, and secondary amyloidosis in 0.9%. In the multivariate logistic regression analysis, lymphadenopathy (OR 2.85, 95% CI 1.03-7.91, p = 0.044) and the systemic score system (SSC) index (OR 1.86, 95% CI 1.29-2.69, p = 0.001) were independently associated with the development of non-classical clinical manifestations. In contrast, typical exanthema was associated with a reduced risk of these complications (OR 0.32, 95% CI 0.11-0.95, p = 0.041). Conclusions: In addition to the typical clinical manifestations and MAS, a significant proportion of patients with AOSD develop uncommon complications, some of which can be potentially life-threatening. These should be considered in the evaluation and follow-up of patients. Early recognition and prompt management are crucial to significantly reduce morbidity and mortality.
目的:探讨成人发病斯蒂尔氏病(AOSD)除巨噬细胞激活综合征(MAS)外的非典型或非典型并发症的患病率和临床谱,并确定其发生的相关因素。方法:对西班牙斯蒂尔氏病登记的AODS病例进行多中心横断面研究。结果:本研究纳入107例患者(67%为女性),其中64例(59.8%)出现非典型性并发症。其中巨噬细胞激活综合征(9.5%)、非典型皮肤表现(38.8%)、心脏受累(包括心包炎、心肌炎、肺动脉高压和非感染性心内膜炎)、胸膜炎(28.9%)、短暂性肺浸润(4%)、明显头痛(14.1%)、伴有腹膜炎的下腹痛(8.4%)和继发性淀粉样变性(0.9%)。在多因素logistic回归分析中,淋巴结病变(OR 2.85, 95% CI 1.03-7.91, p = 0.044)和系统评分系统(SSC)指数(OR 1.86, 95% CI 1.29-2.69, p = 0.001)与非经典临床表现的发生独立相关。相比之下,典型的前列腺癌与这些并发症的风险降低相关(OR 0.32, 95% CI 0.11-0.95, p = 0.041)。结论:除典型的临床表现和MAS外,相当比例的AOSD患者出现罕见的并发症,其中一些可能危及生命。在对患者进行评估和随访时应考虑这些因素。早期发现和及时处理对于显著降低发病率和死亡率至关重要。
期刊介绍:
Journal of Clinical Medicine (ISSN 2077-0383), is an international scientific open access journal, providing a platform for advances in health care/clinical practices, the study of direct observation of patients and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals.
Unique features of this journal:
manuscripts regarding original research and ideas will be particularly welcomed.JCM also accepts reviews, communications, and short notes.
There is no limit to publication length: our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible.